Daphne C Tse

Title: Innovations by Daphne C. Tse

Introduction

Daphne C. Tse is a notable inventor based in Duarte, CA. She has made significant contributions to the field of medical technology, particularly in the development of fibrinogen-containing compositions. With a total of 2 patents, her work has the potential to impact various medical applications.

Latest Patents

Daphne's latest patents include a method of preparing a topical fibrinogen complex. This method involves preparing a fibrinogen-containing composition derived from human plasma by separating a cryoprecipitate from the plasma. The process includes suspending the cryoprecipitate in a salt-containing buffer and treating the supernatant by affinity-chromatography on a lysine-bound solid matrix. This allows plasminogen to adsorb, leading to the collection of a fraction containing less than 10 µg/ml plasminogen. The resulting fibrinogen-containing composition is advantageous as it contains a low amount of plasminogen, eliminating the need for additional fibrinolysis inhibitors.

Additionally, her patent on the topical fibrinogen complex describes a composition that reacts with thrombin to function as a fibrin sealant. This composition is characterized by being free of detectable levels of lipid-enveloped virus activity, prothrombin complex, and active thrombin, while containing no protease inhibitors or other non-human proteins. The method for producing this composition is also detailed in her patent.

Career Highlights

Daphne C. Tse is currently associated with Baxter International Inc., a leading company in the healthcare sector. Her work at Baxter focuses on innovative solutions that enhance patient care and safety.

Collaborations

Daphne collaborates with talented individuals such as Samia S. Mankarious and Shu Len Liu, contributing to a dynamic team that drives innovation in medical technology.

Conclusion

Daphne C. Tse's contributions to the field of medical technology through her patents and work at Baxter International Inc. highlight her role as a significant inventor. Her innovative approaches to fibrinogen-containing compositions have the potential to improve medical treatments and patient outcomes.